Monograph
C07AA06 - Timolol |
Not porphyrinogenic |
NP |
Rationale
Occasional clinical observation of tolerance.Two references state non-porphyrinogenicity.
Chemical description
Beta-receptor blocking agent. Partly metabolized in the liver by CYP 2D6. Andersson, patient report (n=1): tolerated. South African list: use. French list: authorized. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Belgium
United Kingdom
Norway© NAPOS 2024